Wird geladen...
Dosimetry of [(177)Lu]-DO3A-VS-Cys(40)-Exendin-4 – impact on the feasibility of insulinoma internal radiotherapy
[(68)Ga]-DO3A-VS-Cys(40)-Exendin-4 has been shown to be a promising imaging candidate for targeting glucagon like peptide-1 receptor (GLP-1R). In the light of radiotheranostics and personalized medicine the (177)Lu-labelled analogue is of paramount interest. In this study we have investigated the or...
Gespeichert in:
| Veröffentlicht in: | Am J Nucl Med Mol Imaging |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
e-Century Publishing Corporation
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4396004/ https://ncbi.nlm.nih.gov/pubmed/25973333 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|